Drug Trial Radar · NCT02069665
Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
Last checked: Nov 20, 2026Latest source record: Feb 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
451
Actual
Start
Dec 2011
Primary completion
Jul 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Liaoning University of Traditional Chinese MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Beijing University of Chinese Medicine
- First posted
- Feb 24, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 months, up to 59 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial.
Conditions
- Pneumonia
Interventions
Fuxiong SanOther
external application; 8-10cm wide, 0.3-0.5cm thick; 10mins for patient aged 1 to 3-year old; 15mins for those aged 3 to 5-year old; once daily
Xiyanping injectionDrug
ivd. 5 to 10 mg/(kg•d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection.
Ribavirin InjectionDrug
ivd. 10 to 20 mg/(kg•d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection.
Xiaoer Qingfei Heji (mixture)Drug
children aged 6 months to 1 year old: 10 ml, orally taken three times daily; children aged 1 to 3 year old: 15 ml, orally taken three times daily; children aged 3 to 5 year old: 20 ml, orally taken three times daily;
Zhi Ke SanDrug
children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily;
Hua Tan SanDrug
children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily;
Guaifenesin SyrupDrug
children aged 6 months to 1 year old: 3ml, orally taken three times daily; children aged 1 to 3 year old: 5ml, orally taken three times daily; children aged 3 to 5 year old: 8ml, orally taken three times daily;
Ibuprofen SuspensionDrug
taken under prescription
salbutamolDrug
taken under prescription
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cured rateTime frame: Every day since receiving treatment, all together 10 days (times)
- Effectiveness time windowTime frame: Every day since receiving treatment, all together 10 days (times)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Affiliated Children's Hospital of Capital University of Medical Sciences
Beijing, Beijing Municipality, China
Guangzhou Children's Hospital
Guangzhou, Guangdong, China
Affiliated Children's Hospital of Dalian Medical University
Dalian, Liaoning, China
Affiliated Hospital of Liaoning University of TCM
Shenyang, Liaoning, China
Affiliated Hospital of Shandong University of TCM
Ji'nan, Shandong, China
Affiliated Longhua Hospital of Shanghai University of TCM
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.